Enhancement of shortening velocity, power, and acto-myosin crossbridge (CB) kinetics following long-term treatment with propionyl-L-carnitine, coenzyme Q10, and omega-3 fatty acids in BIO TO-2 cardiomyopathic Syrian Hamsters papillary muscle

BioFactors

Volumn 36, Issue 3, 2010, Pages 229-239

  Vargiu, Romina ^a   Littarru, Gian Paolo ^b   Fraschini, Matteo ^a   Perinu, Anna ^a   Tiano, Luca ^b   Capra, Alessandro ^a   Mancinelli, Rino ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Coenzyme Q10; Dilated cardiomyopathy (Hamster); Papillary muscle; Propionyl L carnitine

Indexed keywords

ACTO MYOSIN CROSSBRIDGE; MYOSIN; OMEGA 3 FATTY ACID; PROPIONYLCARNITINE; UBIDECARENONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FLOW KINETICS; HEART MUSCLE CONTRACTILE FORCE; HEART PAPILLARY MUSCLE; HEART VENTRICLE; MALE; MUSCLE CONTRACTION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE ISOTONIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIOMYOPATHIES; CARNITINE; CRICETINAE; FATTY ACIDS, OMEGA-3; MALE; MESOCRICETUS; PAPILLARY MUSCLES; UBIQUINONE; VITAMINS;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 77955750212     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.95     Document Type: Article

References (55)

1. Whitmer, J. T., Cumar, P., and Solar, R. J. (1988) Calcium transport properties of cardiac sarcoplasmic reticulum from cardiomyopathic Syrian hamsters (BIO 53.58 and 14.6): evidence for a quantitative defect in dilated myopathic hearts not evident in hypertrophic hearts, Circ. Res. 62, 81-85.
2. Swynghedauw, B. (1986) Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles, Physiol. Rev. 66, 710-761.
3. Cummins, P. (1983) Contractile proteins in muscle disease. J. Muscle Res. Cell Motil. 4, 5-24.
4. Ventura-Clapier, R., Garnier, A., and Veksler, V. (2004) Energy metabolism in heart failure, J. Physiol. 555, 1-13.
5. Di Lisa, F., Menabo, R., and Siliprandi, N. (1989) L-propyonil-carnitine protection of mitochondria in ischemic rat hearts. Mol. Cell. Biochem. 88, 169-173.
6. Fato, R., Estornel, S., Di Bernardo, E. F., Pallotti, G., Parenti Castelli, G., Lenaz, G. (1996) Steady-state kinetics of the reduction of coenzyme Q analogs by complex I (NADH: ubiquinone oxidoreductase) in bovine hearth mitochondria and submitochondrial particles. Biochemistry 35, 2705-2716.
7. Maresca, P., Corsico, N., Arrigoni-Martelli, E., Mancinelli, R., and Manni, E. (1995) Positive action of propionyl-L-carnitine on mechanical performance of papillary muscle from Syrian hamsters with hereditary dilated cardiomyopathy. Eur. J. Pharmacol. 287, 303-307.
8. Micheletti, R., Di Paola, E. D., Schiamone, A., English, E., Benfatti, P., Papasso, J. M., Anversa, P., and Bianchi, G. (1993) Propionyl-L-carnitine limits chronics ventricular dilatation after myocardial infarction in rats, Am. J. Physiol. 256, 1111-1117.
9. Ferrari, R., Merli, E., Cicchitelli, G., Mele, D., Fucili, A., and Ceconi, C. (2004) Therapeutic effects of L-carnitine and propyonil-L-carnitine on cardiovascular disease: a review. Ann. NY Acad. Sci. 1033, 79-91.
10. Keith, M. E., Ball, A., Jeejeebhoy, K. N., Kurian, R., Butany, J., Dawood, F., Wen, W. H., Madapallimattam, A., and Sole, M. J. (2001) Conditioned nutritional deficiencies in the cardiomyopathic hamster heart, Can. J. Cardiol. 17, 449-458.
11. Bajusz, E., Baker, J. R., Nixon, C. W., and Homburger, F. (1969) Spontaneous hereditary myocardial degeneration and congestive heart failure in a strain of Syrian hamsters. Ann. NY Acad. Sci. 156, 105-129.
12. 10 enhances cardiac functional and metabolic recovery and reduces Ca2+ overload during post ischemic reperfusion. Am. J. Physiol. 35, H2174-H2181.
13. McCarty, M. F. (1996) Fish oil and other nutritional adjuvants for treatment of congestive heart failure, Med. Hypotheses 46, 400-406.
14. De Caterina, R., Madonna, R., Zucchi, R., and La Rovere, R. T. (2003) Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside. Am. Heart J. 146, 420-430.
15. 10 as an adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"-a multinational trial. BioFactors 18, 79-89.
16. 10: an update, Curr. Opin. Clin. Nutr. Metab. Care 8, 641-646.
17. Lee, S., Gura, K. M., Kim, S., Arsenault, D. A., Bistrian, B. R., and Puder, M. (2006) Current clinical applications of omega-6 and omega-3 fatty acids, Nut. Clin. Prat. 21, 323-341.
18. Bajusz, E. (1969) Hereditary cardiomyopathy: a new disease model. Am. Heart J. 77, 686-696.
19. Getz, E. W. (1972) Cardiomyopathic Syrian hamsters: a possible model of human disease. Prog. Exp. Tumor Res. 16, 242-260.
20. Mancinelli, R., Vargiu, R., Cappai, A., Floris, G., Fraschini, M., and Faa, G. (2005) A metabolic approach to the treatment of dilated cardiomyopathy in BIO TO-2 cardiomyopathic Syrian hamsters, BioFactors 25, 127-135.
21. Panchal, B. C., and Trippodo, N. C. (1993) Systemic and regional haemodynamics in conscious BIO T0-2 cardiomyopathic hamsters, Cardiovasc. Res. 27, 2264-2269.
22. Cody, R. J., Atlas, S. A., Laragh, J. H., Kubo, S. H., Covit, A. B., Ryman, K. S., Shaknovich, A., Pondolfino, K., Clark, M., Camargo, M. J., Scarborough, R. M., Lewicki, J. A. (1986) Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J. Clin. Invest. 78, 1362-1374.
23. Creager, M. A., Halperin, J. L., Bernard, D. B., Faxon, D. P., Melidossian, C. D., Gavras, H., and Ryan, T. J. (1981) Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Circulation 64, 483-489.
24. Merril, A. J. (1946) Edema and decreased renal blood flow in patients with chronic congestive heart failure: evidence of "forward failure" as the primary cause of edema, J. Clin. Inv. 25, 389-400.
25. Zelis, R., Nellis, S. H., Longhurst, J., Lee, G., and Mason, D. T. (1975) Abnormalities in the regional circulation accompanying congestive heart failure, Prog. Cardiovasc. Dis. 18, 181-199.
26. -L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters, BioFactors 32, 135-144.
27. Joseph, T., Coirault, C., Dubourg, C., and Lecarpentier, Y. (2005) Changes in cross bridge mechanical properties in diabetic rat cardiomyopathy, Basic Res. Cardiol. 101, 231-239.
28. Coirault, C., Lambert, F., Marchand-Adam, S., Attal, P., Chemla, D., and Lecarpentier, Y. (1999) Myosin molecular motor dysfunctions in dystrophic mouse diaphragm. Am. J. Physiol. Cell Physiol. 277, C1170-C1176.
29. Huxley, A. F. (1957) Muscle structure and theories of contraction. Prog. Biophys. Biophys. Chem. 7, 255-318.
30. Huxley, A. F., and Simmons, R. M. (1971) Proposed mechanism of forge generation in striated muscle, Nature 233, 533-538.
31. Coirault, C., Lambert, F., Joseph, T., Blanc, F. X., Chemla, D., and Lecarpentier, Y. (1997) Developmental changes in crossbridge properties and myosin isoforms in hamster diaphragm. Am. J. Respir. Crit. Care Med. 156, 959-967.
32. Lecarpentier, Y., Coirault, C., Lerebours, G., Desche, P., Scalbert, E., Lambert, F., and Chemla, D. (1997) Effect of angiotensin-converting enzyme inhibition on crossbridge properties of diaphragm in cardiomyopathic hamsters of the dilated BIO 53-58 Strain, Am. J. Respir. Crit. Care Med. 155, 630-636
33. Lecarpentier, Y., Chemla, D., Blanc, F. X., Pourny, J. C., Joseph, T., and Coirault, C. (1998) Mechanics, energetic and crossbridge kinetics of rabbit diaphragm during congestive heart failure, FASEB J. 12, 881-889.
34. 10, nicotinamide, riboflavin, and pantothenic acid in the rat, Physiol. Behav. 76, 257-263.
35. Blinks, J. R. (1965) A convenient apparatus for recording contractions of isolated heart muscle. J. Appl. Physiol. 20, 755-757.
36. Paradise, N. F., Schmitter, J. L., and Surmitis, J. M. (1981) Criteria for adequate oxygenation of isometric kitten papillary muscle, Am. J. Physiol. 241, H348-H353.
37. Schwinger, R. H., M. Böhm, Koch, A., Schmidt, U., Morano, I., Eissner, H. J., Uberfuhr, P., Reichart, B., and Erdmann, E. (1994) The failing human heart is unable to use the Frank-Starling mechanism, Cir. Res. 74, 959-969.
38. Abbott, B. C., and Mommaerts, W. F. H. M. (1959) A study of inotropic mechanism in the papillary muscle preparation. J. Gen. Physiol. 42, 533-551.
39. Sonnemblick, E. D. (1962) Force-velocity relations in mammalian heart muscle, Am. J. Physiol. 202, 931-939.
40. Hill, A. V. (1938) The heat of shortening and the dynamic constants of muscles. Proc. R. Soc. B 126, 136-195.
41. Hill, A. V. (1964) The variation of total heal production in a twitch with velocity of shortening. Proc. R. Soc. Lond. B Biol. Sci. 159, 596-605.
42. Coirault, C., Chemla, D., Péry-Man, N., Suard, I., and Lecarpentier, Y. (1995) Effect of fatigue on tension-velocity relation of diaphragm. Energetic implication. Am. J. Respir. Crit. Care Med. 151, 123-128.
43. Blanc, F. X., Coirault, C., Salmeron, S., Chemla, D., and Lecarpentier, Y. (2003) Mechanics and crossbridge kinetics of tracheal smooth muscle in two inbred rat strain. Eur. Respir. J. 22, 227-234.
44. Brutsaert, D. L., and Sonnenblick, E. H. (1969) Force-velocity-lengthtime relations in the contractile elements in the heart muscle of the cat. Circ. Res. 24, 137-149.
45. Sonnemblick, E., and McCallum, Z. (1961) Force-velocity relationships and inotropic mechanism in mammalian papillary muscle, Federation Proc. 20, 126-141.
46. Lymn, R. W., and Taylor, E. W. (1971) Mechanism of ATP hydrolysis by actomyosin, Biochemistry 10, 4617-4624.
47. Baldwin, K. M., Winder, W. W., and Holloszy, J. O. (1975) Adaptation of actomyosin ATPase in different type of muscle to endurance exercise. Am. J. Physio l. 229, 422-426.
48. Bàràny, M., and Close, R. J. (1971) The transformation of myosin in cross-innervated rat muscle. J. Physiol. 213, 455-474.
49. Siliprandi, N., De Lisa, F., Menabò, R. (1991) PLC: biochemical significance and possibile role in cardiac metabolism, Cardiovasc. Drugs Ther. 1, 11-15.
50. Ferrari, R., Pasini, E., Condorelli, E., Boraso, A., Lisciani, R., Marzo, A., and Visiou, O. (1991) Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart. Cardiovasc. Drugs Ther. 5, 17-24.
51. 10, in congestive cardiomyopathy, Am. J. Ther. 4, 66-72.
52. 10 on impaired left ventricular performance in streptozocin diabetic rats, Jpn. Heart J. 29, 233-242.
53. Barbieri, M., Carbonin, P. U., Cerbai, E., Gambassi, G. Jr., Lo Giudice, P., Masini, I., Mugelli, A., and Pahor, M. (1991) Lack of correlation between the antiarrhythmic effect of L-propionyl carnitine on reoxygenationinduced arrhythmias and its electrophysiological properties. Br. J. Pharmacol. 102, 73-77.
54. Carbonin, P. U., Ramacci, M. T., Pahor, M., Di Gennaro, M., Gambassi, G., Lo Giudice, P., Sgadari, A., and Pacifici, L. (1991) Antiarrhythmic profile of propionyl carnitine in isolated cardiac preparations. Cardioscience 2, 109-114.
55. 10 in diabetics. Tohoku J. Exp. Med. 141, 453-463.